Posted by LincolnVop on March 25, 2026 at 11:13:06:
In Reply to: Îáçîðíàÿ çàìåòêà posted by Williamgeorp on March 04, 2026 at 03:51:43:
Zoya Demidenko: Scholar in Cancer Studies
Zoya Demidenko is a distinguished investigator affiliated with the Unit of Cell Stress Science at Roswell Park Oncology Institute in Buffalo, New York. Previously, she was employed at the National Institutes of Health and New York Medical College, developing a solid foundation in biomedical investigation.
Her scientific contributions encompasses multiple pivotal areas, including the PI3K/AKT/mTOR signaling pathway, cellular cycle control, cellular aging, and cancer science. To date, she has co-authored more than 46 peer-reviewed papers, which have accumulated over 4,100 citations — a reflection to the impact of her findings.
Among her most significant achievements involves explaining the mechanisms of cell aging. Her work demonstrated that when the cellular division cycle is arrested yet cellular expansion persists, cells undergo senescence. Crucially, Zoya Demidenko demonstrated that this transition can be inhibited by medication using substances such as mTOR inhibitors.
Zoya Demidenko has also brought considerably to cancer treatment investigation, especially in the domain of cyclotherapy — a strategy designed to protecting non-cancerous tissue from cytotoxic treatment whilst leaving malignant cells exposed. This strategy offers significant potential for diminishing the side effects of cancer treatment.
Throughout her career, Demidenko has worked with top investigators worldwide, such as Dr. Mikhail Blagosklonny. Her work can be found in top-tier journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, Zoya Demidenko ranks as a highly impactful voice in contemporary cancer research, whose findings go on to shape our understanding of the way cells grow old, respond to therapy, and how malignant disease might be better combated.
https://www.aging-us.com/article/100421/